# Peter Cabot
**Source**: https://about.uq.edu.au/experts/72
**Parent**: https://about.uq.edu.au/faculties-institutes/hmbs/about/leaders
Professor
# Peter Cabot
Email:
: [pcabot@pharmacy.uq.edu.au](mailto:pcabot@pharmacy.uq.edu.au)
Phone:
: [+61 7 334 61854](tel:+61 7 334 61854)
## Positions
Head of School, Pharmacy and Pharmaceutical Sciences
: Faculty of Health, Medicine and Behavioural Sciences
Affiliate of Centre for Innovation in Pain and Health Research (CIPHeR)
: Centre for Innovation in Pain and Health Research
: Faculty of Health, Medicine and Behavioural Sciences
## Overview
### Background
Peter Cabot is the Professor and Head of School in the School of Pharmacy. He joined the School staff in this position in 1999 after completing postdoctoral positions at Johns Hopkins University, Baltimore USA, The NIH, Baltimore USA and within the School of Pharmacy at UQ.
The primary focus of my research is on the elucidation of the peripheral mechanisms involved in analgesia associated with inflammation. Key discoveries were made in this field that highlighted the importance of the immune system in inflammatory pain. The results of which were published in the notable journals; JBC, PAIN, Nature Medicine and The Journal of Clinical Investigation.
Read more
Read less
### Availability
Professor Peter Cabot is:
: Available for supervision
: Media expert
### Fields of research
[Clinical sciences](https://about.uq.edu.au/experts/search?research-field=4979)
[Pharmacology and pharmaceutical sciences](https://about.uq.edu.au/experts/search?research-field=4819)
### Qualifications
- Bachelor of Applied Science, Charles Sturt University
- Doctor of Philosophy, The University of Queensland
### Research interests
- #### Opioids in inflammation
In the area I work as a translational scientist, exploring drug discovery of novel opioids and inflammatory mechanisms as well as developing new alternatives, paring this with translational work into preclinical and clinical studies looking for better outcomes for patients.
Read more
Read less
- #### Biotransformation of Opioids in Disease
Read more
Read less
- #### Pain in Inflammatory Diseases
Read more
Read less
- #### Natural Products Drug Discovery
Read more
Read less
### Research impacts
Our current research is focussed on novel opioid ligands that target opioid receptors aligned with less addictive properties, bioactivity of endogenous and natural products that may provide insights into better pain therapy or reduction in inflammatory disorders such as sinusitis.
Read more
Read less
## Works
[Search Professor Peter Cabot’s works on UQ eSpace](http://espace.library.uq.edu.au/list/author_id/130)
[All
(161)](https://about.uq.edu.au/experts-publication/72/all)
[Journal Article
(92)](https://about.uq.edu.au/experts-publication/72/4748)
[Other Outputs
(5)](https://about.uq.edu.au/experts-publication/72/4749)
[Conference Publication
(63)](https://about.uq.edu.au/experts-publication/72/4751)
[Book Chapter
(1)](https://about.uq.edu.au/experts-publication/72/4752)
2024
Conference Publication
##### Bivalent peptide agonists targeting peripheral Kappa and Nociceptin heterodimer opioid receptors for the treatment of pain and opioid use disorder
Habib, Muhaimin, Saifuddin, Danial, Robitaille, Mélanie and Cabot, Peter (2024). Bivalent peptide agonists targeting peripheral Kappa and Nociceptin heterodimer opioid receptors for the treatment of pain and opioid use disorder. ASCEPT, APFP & APSA Joint Conference, Melbourne, VIC Australia, 1 - 4 December 2024.
[Bivalent peptide agonists targeting peripheral Kappa and Nociceptin heterodimer opioid receptors for the treatment of pain and opioid use disorder](https://espace.library.uq.edu.au/view/UQ:00e253c)
2024
Conference Publication
##### Targeting peripheral mu and delta heterodimer receptors with bivalent opioid peptides
Zhang, Junkai, Robitaille, Melanie, Saifuddin, Danial, Ross, Benjamin and Cabot, Peter (2024). Targeting peripheral mu and delta heterodimer receptors with bivalent opioid peptides. ASCEPT, APFP & APSA Joint Conference, Melbourne, VIC Australia, 1 - 4 December 2024.
[Targeting peripheral mu and delta heterodimer receptors with bivalent opioid peptides](https://espace.library.uq.edu.au/view/UQ:8eab177)
2024
Other Outputs
##### Peptides and uses thereof
Tupally, Karnaker, Cabot, Peter, Nandkumar, Ajit and Parekh, Harendra (2024). Peptides and uses thereof. EP4175970A1.
[Peptides and uses thereof](https://espace.library.uq.edu.au/view/UQ:37ac1c3)
2024
Journal Article
##### C-reactive protein (CRP) is associated with chronic pain independently of biopsychosocial factors
Farrell, Scott F., Armfield, Nigel R., Cabot, Peter J., Elphinston, Rachel A., Gray, Paul, Minhas, Gunjeet, Collyer, Martin R. and Sterling, Michele (2024). C-reactive protein (CRP) is associated with chronic pain independently of biopsychosocial factors. The Journal of Pain, 25 (2), 476-496. doi: 10.1016/j.jpain.2023.09.008
[C-reactive protein (CRP) is associated with chronic pain independently of biopsychosocial factors](https://espace.library.uq.edu.au/view/UQ:3433591)
2023
Conference Publication
##### Leveraging eportfolios to support a learner-centred approach in the Master of Pharmaceutical Industry Practice Program
Cabot, Peter John, Bowker, Shari and Slade, Christine (2023). Leveraging eportfolios to support a learner-centred approach in the Master of Pharmaceutical Industry Practice Program. 2023 Eportfolio Forum: Emerging, Connecting, Sustaining, Darwin, NT, Australia, 11-12 October 2023. Adelaide, SA, Australia: ePortfolios Australia.
[Leveraging eportfolios to support a learner-centred approach in the Master of Pharmaceutical Industry Practice Program](https://espace.library.uq.edu.au/view/UQ:68270d6)
2023
Conference Publication
##### Bivalent kappa-selective opioid peptides with enhanced metabolic stability and potency
Saifuddin, D., Lohman, R.-J., Tupally, K., Parekh, H. and Cabot, P. (2023). Bivalent kappa-selective opioid peptides with enhanced metabolic stability and potency. 81st FIP World Congress Of Pharmacy And Pharmaceutical Sciences, Brisbane, QLD Australia, 24-28 September 2023. PKP Publishing.
[Bivalent kappa-selective opioid peptides with enhanced metabolic stability and potency](https://espace.library.uq.edu.au/view/UQ:4167fe8)
2023
Conference Publication
##### Ivermectin effects on interleukin-6 induced nuclear translocation of STAT3 in a macrophage based cell line
Cabot, Peter, Daniel, Sona and Alawie, Rayan (2023). Ivermectin effects on interleukin-6 induced nuclear translocation of STAT3 in a macrophage based cell line. 81st FIP World Congress Of Pharmacy And Pharmaceutical Sciences, Brisbane, QLD Australia, 24-28 September 2023. PKP Publishing. doi: 10.46542/pe.2023.236.314328
[Ivermectin effects on interleukin-6 induced nuclear translocation of STAT3 in a macrophage based cell line](https://espace.library.uq.edu.au/view/UQ:46ff1cb)
2023
Journal Article
##### Exploring the therapeutic potential of an antinociceptive and anti-inflammatory peptide from wasp venom
Galante, Priscilla, Campos, Gabriel A. A., Moser, Jacqueline C. G., Martins, Danubia B., Dos Santos Cabrera, Marcia P., Rangel, Marisa, Coelho, Luiza C., Simon, Karina S., Amado, Veronica M., de A. I. Muller, Jessica, Koehbach, Johannes, Lohman, Rink-Jan, Cabot, Peter J., Vetter, Irina, Craik, David J., Toffoli-Kadri, Monica C., Monge-Fuentes, Victoria, Goulart, Jair T., Schwartz, Elisabeth F., Silva, Luciano P., Bocca, Anamelia L. and Mortari, Márcia R (2023). Exploring the therapeutic potential of an antinociceptive and anti-inflammatory peptide from wasp venom. Scientific Reports, 13 (1) 12491, 1-15. doi: 10.1038/s41598-023-38828-w
[Exploring the therapeutic potential of an antinociceptive and anti-inflammatory peptide from wasp venom](https://espace.library.uq.edu.au/view/UQ:77916ae)
2023
Journal Article
##### Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy
Lohman, Rink-Jan, Tupally, Karnaker Reddy, Kandale, Ajit, Cabot, Peter J and Parekh, Harendra S (2023). Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy. Frontiers in Pharmacology, 14 1150313, 1150313-14. doi: 10.3389/fphar.2023.1150313
[Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy](https://espace.library.uq.edu.au/view/UQ:7354975)
2023
Journal Article
##### National wastewater reconnaissance of analgesic consumption in Australia
Ahmed, Fahad, Tscharke, Benjamin, O’Brien, Jake W., Hall, Wayne D., Cabot, Peter J., Sowa, P. Marcin, Samanipour, Saer and Thomas, Kevin V. (2023). National wastewater reconnaissance of analgesic consumption in Australia. Environmental Science and Technology, 57 (4), 1712-1720. doi: 10.1021/acs.est.2c06691
[National wastewater reconnaissance of analgesic consumption in Australia](https://espace.library.uq.edu.au/view/UQ:07794aa)
2022
Journal Article
##### Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy
Lohman, Rink-Jan, Tupally, Karnaker Reddy, Kandale, Ajit, Cabot, Peter J. and Parekh, Harendra S. (2022). Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy. British Journal of Pharmacology, 180 (1), 129-129. doi: 10.1111/bph.15862
[Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy](https://espace.library.uq.edu.au/view/UQ:fe8486a)
2022
Journal Article
##### Application of mesoporous silica nanoparticles in cancer therapy and delivery of repurposed anthelmintics for cancer therapy
Koohi Moftakhari Esfahani, Maedeh, Alavi, Seyed Ebrahim, Cabot, Peter J., Islam, Nazrul and Izake, Emad L. (2022). Application of mesoporous silica nanoparticles in cancer therapy and delivery of repurposed anthelmintics for cancer therapy. Pharmaceutics, 14 (8) 1579, 1-27. doi: 10.3390/pharmaceutics14081579
[Application of mesoporous silica nanoparticles in cancer therapy and delivery of repurposed anthelmintics for cancer therapy](https://espace.library.uq.edu.au/view/UQ:7bc2f5f)
2022
Journal Article
##### β-lactoglobulin-modified mesoporous silica nanoparticles: a promising carrier for the targeted delivery of fenbendazole into prostate cancer cells
Esfahani, Maedeh Koohi Moftakhari, Alavi, Seyed Ebrahim, Cabot, Peter J., Islam, Nazrul and Izake, Emad L. (2022). β-lactoglobulin-modified mesoporous silica nanoparticles: a promising carrier for the targeted delivery of fenbendazole into prostate cancer cells. Pharmaceutics, 14 (4) 884, 884. doi: 10.3390/pharmaceutics14040884
[β-lactoglobulin-modified mesoporous silica nanoparticles: a promising carrier for the targeted delivery of fenbendazole into prostate cancer cells](https://espace.library.uq.edu.au/view/UQ:023f442)
2021
Journal Article
##### Pegylated mesoporous silica nanoparticles (MCM-41): a promising carrier for the targeted delivery of fenbendazole into prostrate cancer cells
Esfahani, Maedeh Koohi Moftakhari, Alavi, Seyed Ebrahim, Cabot, Peter J., Islam, Nazrul and Izake, Emad L. (2021). Pegylated mesoporous silica nanoparticles (MCM-41): a promising carrier for the targeted delivery of fenbendazole into prostrate cancer cells. Pharmaceutics, 13 (10) 1605, 1605. doi: 10.3390/pharmaceutics13101605
[Pegylated mesoporous silica nanoparticles (MCM-41): a promising carrier for the targeted delivery of fenbendazole into prostrate cancer cells](https://espace.library.uq.edu.au/view/UQ:ffab9ea)
2021
Other Outputs
##### Peptides and uses thereof
Parekh, Harendra, Tupally, Karnaker, Cabot, Peter and Kandale, Ajit (2021). Peptides and uses thereof. 2021300202.
[Peptides and uses thereof](https://espace.library.uq.edu.au/view/UQ:e7ea78a)
2021
Conference Publication
##### Novel opioid peptides as allosteric modulators of nociception
Saifuddin, Danial, Lohman, Rink-Jan, Tupally, Karnaker Reddy, Parekh, Harendra S. and Cabot, Peter J. (2021). Novel opioid peptides as allosteric modulators of nociception. ASMR medical research week: Queensland virtual symposium, Online, 9-10 June 2021.
[Novel opioid peptides as allosteric modulators of nociception](https://espace.library.uq.edu.au/view/UQ:6b02478)
2021
Journal Article
##### Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy
Esfahani, Maedeh Koohi Moftakhari, Islam, Nazrul, Cabot, Peter J. and Izake, Emad L. (2021). Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy. ACS Biomaterials Science and Engineering, 8 (10) acsbiomaterials.1c00066, 4153-4162. doi: 10.1021/acsbiomaterials.1c00066
[Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy](https://espace.library.uq.edu.au/view/UQ:d7dda84)
2021
Journal Article
##### Developing GLP-1 conjugated self-assembling nanofibers using copper-catalyzed alkyne–azide cycloaddition and evaluation of their biological activity
Alavi, Seyed Ebrahim, Cabot, Peter J., Raza, Aun and Moyle, Peter M. (2021). Developing GLP-1 conjugated self-assembling nanofibers using copper-catalyzed alkyne–azide cycloaddition and evaluation of their biological activity. Bioconjugate Chemistry, 32 (4), 810-820. doi: 10.1021/acs.bioconjchem.1c00091
[Developing GLP-1 conjugated self-assembling nanofibers using copper-catalyzed alkyne–azide cycloaddition and evaluation of their biological activity](https://espace.library.uq.edu.au/view/UQ:d8d7410)
2021
Journal Article
##### Liquid CO2 formulated mesoporous silica nanoparticles for pH-responsive oral delivery of meropenem
Raza, Aun, Sime, Fekade Bruck, Cabot, Peter J., Roberts, Jason A., Falconer, James R., Kumeria, Tushar and Popat, Amirali (2021). Liquid CO2 formulated mesoporous silica nanoparticles for pH-responsive oral delivery of meropenem. ACS Biomaterials Science and Engineering, 7 (5) acsbiomaterials.0c01284, 1836-1853. doi: 10.1021/acsbiomaterials.0c01284
[Liquid CO2 formulated mesoporous silica nanoparticles for pH-responsive oral delivery of meropenem](https://espace.library.uq.edu.au/view/UQ:f106d77)
2020
Journal Article
##### Oral meropenem for superbugs: challenges and opportunities
Raza, Aun, Ngieng, Shih Chen, Sime, Fekade Bruck, Cabot, Peter J., Roberts, Jason A., Popat, Amirali, Kumeria, Tushar and Falconer, James R. (2020). Oral meropenem for superbugs: challenges and opportunities. Drug Discovery Today, 26 (2), 551-560. doi: 10.1016/j.drudis.2020.11.004
[Oral meropenem for superbugs: challenges and opportunities](https://espace.library.uq.edu.au/view/UQ:f01effd)
## Funding
### Past funding
- 2022 - 2024
Development of small nerve fibre pathology in chronic whiplash-associated disorder (RBWH Foundation Grant administered by MNHHS)
Royal Brisbane and Women's Hospital Foundation
[Open grant](https://about.uq.edu.au/experts/project/54229)
- 2018
High-throughput ion channel pharmacology
UQ Major Equipment and Infrastructure
[Open grant](https://about.uq.edu.au/experts/project/34791)
- 2016
Establishing a High-Throughput, Microwave-Assisted Automated Peptide Synthesis Facility at PACE
UQ Major Equipment and Infrastructure
[Open grant](https://about.uq.edu.au/experts/project/28293)
- 2015
Murine behavioural phenotyping facility
UQ Major Equipment and Infrastructure
[Open grant](https://about.uq.edu.au/experts/project/23899)
- 2015
The assessment of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells to identify and characterize new therapeutic targets for diseases
UQ Major Equipment and Infrastructure
[Open grant](https://about.uq.edu.au/experts/project/23894)
- 2014
A medium-throughput cell isolation and analysis suite
UQ Major Equipment and Infrastructure
[Open grant](https://about.uq.edu.au/experts/project/21571)
- 2014 - 2015
Perioperative opioids and tumour growth and metastasis
Australian & New Zealand College of Anaesthetists
[Open grant](https://about.uq.edu.au/experts/project/21192)
- 2010
Analytical instrumentation enabling rapid compound separation and chemical structure analysis via mass fingerprinting
UQ Major Equipment and Infrastructure
[Open grant](https://about.uq.edu.au/experts/project/11967)
- 2010
Cost effective acquisition of an LC-MS/MS system to support CIPDD organics analysis and preclinical and clinical operations
UQ Major Equipment and Infrastructure
[Open grant](https://about.uq.edu.au/experts/project/12001)
- 2010
High content imaging analysis for bioactive and novel therapeutic target evaluation
UQ Major Equipment and Infrastructure
[Open grant](https://about.uq.edu.au/experts/project/11966)
- 2010 - 2014
Why do people keep hurting their back: A longitudinal study of biological, psychological and social predictors
NHMRC Project Grant
[Open grant](https://about.uq.edu.au/experts/project/11802)
- 2009
A core pharmacy facility for molecular biology, expression and protein post translational modification studies in cancer, cardiovascular, pain and epilepsy research
UQ School/Centre Co-Funding
[Open grant](https://about.uq.edu.au/experts/project/46424)
- 2009
Robotics Instrumentation for High Throughput Sample preparation for Increased Productivity of the CIPDD/TetraQ's HPLC-MS/MS Systems for Quantitative Analysis of Organics in a Quality Systems NATA-Acc
UQ Faculty Co-Funding
[Open grant](https://about.uq.edu.au/experts/project/46326)
- 2005
Establishment of an improved model of relapsing MS and the characterisation of the role of Peroxisome Proliferator - activated receoptors alpha and beta
Multiple Sclerosis Research Australia
[Open grant](https://about.uq.edu.au/experts/project/7503)
- 2005
NHMRC\_Equipment Grant = DSI Telemetry System
NHMRC Equipment Grant
[Open grant](https://about.uq.edu.au/experts/project/7509)
- 2004 - 2005
NHMRC\_Equipment Grant\_HLTH\_Pharmacy
NHMRC Equipment Grant
[Open grant](https://about.uq.edu.au/experts/project/6874)
- 2001
Immunosupression and inflammatory Pain: the role of the immune system
Cancer Bequest Fund
[Open grant](https://about.uq.edu.au/experts/project/43930)
- 2001
Mechanical and Thermal Nociceptive thresholds in rats with Immunosuppression and Inflammatory Pain.
UQ Early Career Researcher
[Open grant](https://about.uq.edu.au/experts/project/18211)
- 2001 - 2003
Peripheral Mechanisms of Analgesia in Inflammation
NHMRC Project Grant
[Open grant](https://about.uq.edu.au/experts/project/18133)
- 2000
A pilot study investigating the role of Low Level Laser Therapy (LLLT) in an inflammatory model
Royal Brisbane & Women's Hospital Research Foundation
[Open grant](https://about.uq.edu.au/experts/project/4459)
- 2000
Efficacy of oxycodone relative to morphine for the relief of neuropathic pain in rats
Brain Research Fund
[Open grant](https://about.uq.edu.au/experts/project/88)
- 2000
Investigating the role of Low Level Laser Therapy (LLTP) in an inflammatory model
Centre of Nat. Res. on Disability & Rehab Medicine
[Open grant](https://about.uq.edu.au/experts/project/3828)
- 1999
Site-directed trafficking of opioid producing lymphocytes in localised inflammation and the involvement in pain control
UQ New Staff Research Start-Up Fund
[Open grant](https://about.uq.edu.au/experts/project/44746)
View all 23 past funded projects
View less
## Supervision
### Availability
Professor Peter Cabot is:
: Available for supervision
Looking for a supervisor? Read our advice on [how to choose a supervisor](https://study.uq.edu.au/study-options/phd-mphil-professional-doctorate/how-to-choose-a-supervisor).
### Available projects
- #### Peripheral Mechanisms of Analgesia and the Involvement of the Immune System
Read more
Read less
- #### Opioid biotransformation and inflammation
Read more
Read less
- #### Novel opioid peptides for the treatment of addiction and tolerance
Read more
Read less
### Supervision history
#### Current supervision
- Doctor Philosophy
##### Design, synthesis and pharmacological evaluation of KOPr/NOPr opioid peptides for the treatment of pain and opioid use disorder
Principal Advisor
Other advisors:
[Dr Rink-Jan Lohman](https://about.uq.edu.au/experts/2081), [Associate Professor Harendra Parekh](https://about.uq.edu.au/experts/1262)
- Doctor Philosophy
##### Targeting peripheral kappa and mu bivalent opioid receptors with bivalent opioid peptides for inflammatory pain
Principal Advisor
Other advisors:
[Dr Ben Ross](https://about.uq.edu.au/experts/602), [Dr Melanie Robitaille](https://about.uq.edu.au/experts/29027)
- Master Philosophy
##### Characterisation of novel Dynorphin analogues targeting KOP receptors
Principal Advisor
Other advisors:
[Dr Melanie Robitaille](https://about.uq.edu.au/experts/29027)
- Doctor Philosophy
##### The pharmacological evaluation of beta-endorphin analogues: opioid-based bivalent peptide DB1-7 targeting multiple opioid receptors.
Principal Advisor
Other advisors:
[Associate Professor Harendra Parekh](https://about.uq.edu.au/experts/1262)
- Doctor Philosophy
##### Designing novel bivalent ligands that target the Kappa and nociceptin opioid receptors for reduced side effects
Principal Advisor
Other advisors:
[Dr Rink-Jan Lohman](https://about.uq.edu.au/experts/2081), [Dr Melanie Robitaille](https://about.uq.edu.au/experts/29027)
View all 5 current supervisions
View less
#### Completed supervision
- 2024
Doctor Philosophy
##### [Bivalent opioid constructs as allosteric modulators of nociception](https://espace.library.uq.edu.au/view/UQ:5a9cb7d)
Principal Advisor
Other advisors:
[Dr Rink-Jan Lohman](https://about.uq.edu.au/experts/2081), [Associate Professor Harendra Parekh](https://about.uq.edu.au/experts/1262)
- 2021
Master Philosophy
##### [Formulation design, development and simulated delivery - Sol-gels as a treatment of recalcitrant chronic rhinosinusitis](https://espace.library.uq.edu.au/view/UQ:48cafae)
Principal Advisor
Other advisors:
[Professor Ben Panizza](https://about.uq.edu.au/experts/3185), [Associate Professor Harendra Parekh](https://about.uq.edu.au/experts/1262)
- 2020
Master Philosophy
##### [The development and assessment of a thermoresponsive otic formulation for the treatment of otitis externa](https://espace.library.uq.edu.au/view/UQ:ca774c3)
Principal Advisor
Other advisors:
[Professor Ben Panizza](https://about.uq.edu.au/experts/3185), [Associate Professor Harendra Parekh](https://about.uq.edu.au/experts/1262)
- 2019
Master Philosophy
##### [The in vivo assessment of dexamethasone-based thermoresponsive, mucoadhesive sol-gels in human sinonasal mucosa](https://espace.library.uq.edu.au/view/UQ:d534d96)
Principal Advisor
Other advisors:
[Professor Ben Panizza](https://about.uq.edu.au/experts/3185), [Associate Professor Harendra Parekh](https://about.uq.edu.au/experts/1262)
- 2017
Master Philosophy
##### [Immunomodulatory drug discovery: Ex vivo investigation of biological extracts in a sinonasal explant model of inflammation](https://espace.library.uq.edu.au/view/UQ:699093)
Principal Advisor
Other advisors:
[Professor Ben Panizza](https://about.uq.edu.au/experts/3185)
- 2017
Doctor Philosophy
##### [The immunomodulation of dynorphin 1-17 and its biotransformation fragments on inflammatory signalling pathways](https://espace.library.uq.edu.au/view/UQ:677962)
Principal Advisor
Other advisors:
[Associate Professor Paul Gray](https://about.uq.edu.au/experts/5696), [Dr Michael Morgan](https://about.uq.edu.au/experts/13286)
- 2016
Master Philosophy
##### [Drug discovery in chronic rhinosinusitis: Bioactivity-guided investigation of organic extracts in vitro](https://espace.library.uq.edu.au/view/UQ:406493)
Principal Advisor
Other advisors:
[Professor Ben Panizza](https://about.uq.edu.au/experts/3185)
- 2016
Doctor Philosophy
##### [Using toxins to elucidate the role of voltage-gated sodium channels in pain](https://espace.library.uq.edu.au/view/UQ:377185)
Principal Advisor
Other advisors:
[Professor Irina Vetter](https://about.uq.edu.au/experts/1029)
- 2016
Doctor Philosophy
##### [In vitro and in vivo evaluation of alginate-based microparticles for oral delivery of active entities to sites of inflammation in the colon](https://espace.library.uq.edu.au/view/UQ:387804)
Principal Advisor
- 2015
Doctor Philosophy
##### [Beta-Endorphin Biotransformation and Modulation of Inflammatory Signals](https://espace.library.uq.edu.au/view/UQ:369398)
Principal Advisor
Other advisors:
[Dr Amitha Hewavitharana](https://about.uq.edu.au/experts/1439), [Dr Michael Morgan](https://about.uq.edu.au/experts/13286)
- 2015
Master Philosophy
##### [In vitro anti-inflammatory properties of biological extracts as novel therapeutics for the treatment of chronic rhinosinusitis](https://espace.library.uq.edu.au/view/UQ:363043)
Principal Advisor
Other advisors:
[Professor Ben Panizza](https://about.uq.edu.au/experts/3185)
- 2010
Doctor Philosophy
##### [The peripheral mechanisms of analgesia and the involvement of adhesion molecules - Development of a novel targeted drug delivery system to sites of inflammation and application to peripheral analgesia](https://espace.library.uq.edu.au/view/UQ:192347)
Principal Advisor
Other advisors:
[Dr Amitha Hewavitharana](https://about.uq.edu.au/experts/1439)
- 2009
Doctor Philosophy
##### [Assessment of Fucoidin efficacy in A-peptide induced Alzheimer¿s disease rodent model](https://espace.library.uq.edu.au/view/UQ:177944)
Principal Advisor
Other advisors:
[Emeritus Professor Maree Smith](https://about.uq.edu.au/experts/32)
- 2009
Doctor Philosophy
##### [Functional Roles of Peroxisome Proliferator-Activated Receptor B/O in a Model of Relapsing-Remitting Experimental Autoimmune Encephalomyelitis](https://espace.library.uq.edu.au/view/UQ:167471)
Principal Advisor
Other advisors:
[Professor Gregory Monteith](https://about.uq.edu.au/experts/556)
- Doctor Philosophy
##### MECHANISMS INVOLVED IN FUNCTIONAL INTERACTIONS BETWEEN THE TRANSIENT RECEPTOR POTENTIAL VANILLIOD 1 AND u OPIOID RECEPTOR
Principal Advisor
Other advisors:
[Professor Gregory Monteith](https://about.uq.edu.au/experts/556)
- 2021
Doctor Philosophy
##### [Advanced Oral Antibiotic Formulations](https://espace.library.uq.edu.au/view/UQ:5a8aefb)
Associate Advisor
Other advisors:
[Professor Jason Roberts](https://about.uq.edu.au/experts/1526), [Professor Amirali Popat](https://about.uq.edu.au/experts/2129), [Dr Fekade Sime](https://about.uq.edu.au/experts/13066), [Dr James Robert Falconer](https://about.uq.edu.au/experts/12674)
- 2020
Doctor Philosophy
##### [Design, synthesis and pharmacological evaluation of novel opioid peptides for the treatment of pain and inflammatory diseases](https://espace.library.uq.edu.au/view/UQ:44d9990)
Associate Advisor
Other advisors:
[Associate Professor Harendra Parekh](https://about.uq.edu.au/experts/1262)
- 2020
Doctor Philosophy
##### [Glucagon-like peptide 1 (GLP-1) modifications to improve its utility for the treatment of type 2 diabetes mellitus](https://espace.library.uq.edu.au/view/UQ:d0b6cd2)
Associate Advisor
Other advisors:
[Associate Professor Peter Moyle](https://about.uq.edu.au/experts/1231)
- 2018
Doctor Philosophy
##### Distal limb wound healing in horses: Is there a role for topical compounds?
Associate Advisor
Other advisors:
[Professor Paul Mills](https://about.uq.edu.au/experts/124), [Professor Lisa Nissen](https://about.uq.edu.au/experts/5479), [Associate Professor Kathryn Steadman](https://about.uq.edu.au/experts/1732)
- 2018
Doctor Philosophy
##### [Development and Functional Evaluation of a Corticosteroid-based Mucoadhesive In-Situ Nasal Gelling System for Post-operative Sinusitis](https://espace.library.uq.edu.au/view/UQ:f348f2a)
Associate Advisor
Other advisors:
[Professor Ben Panizza](https://about.uq.edu.au/experts/3185), [Associate Professor Harendra Parekh](https://about.uq.edu.au/experts/1262)
- 2018
Master Philosophy
##### [Development of a lipoid microbubble formulation and in vitro evaluation assisted by ultrasound](https://espace.library.uq.edu.au/view/UQ:1e0c40a)
Associate Advisor
Other advisors:
[Associate Professor Harendra Parekh](https://about.uq.edu.au/experts/1262)
- 2018
Doctor Philosophy
##### [MORPHINE AND CANCER METASTASIS](https://espace.library.uq.edu.au/view/UQ:728256)
Associate Advisor
Other advisors:
[Professor David Sturgess](https://about.uq.edu.au/experts/6072), [Associate Professor Marie-Odile Parat](https://about.uq.edu.au/experts/1912)
- 2017
Doctor Philosophy
##### [Succinylated epsilon-polylysine coated mesoporous silica nanoparticles for pH-responsive oral targeted drug delivery to the colon](https://espace.library.uq.edu.au/view/UQ:677430)
Associate Advisor
Other advisors:
[Dr Ben Ross](https://about.uq.edu.au/experts/602)
- 2017
Doctor Philosophy
##### [Investigation of Selective Anti-Proliferative and Immunomodulatory Properties of Carica Papaya](https://espace.library.uq.edu.au/view/UQ:595961)
Associate Advisor
Other advisors:
[Dr Amitha Hewavitharana](https://about.uq.edu.au/experts/1439)
- 2017
Doctor Philosophy
##### [Regulation of MDA-MB-231 breast cancer cell death by plasma membrane calcium ATPase isoforms and the mitochondrial calcium uniporter](https://espace.library.uq.edu.au/view/UQ:500511)
Associate Advisor
Other advisors:
[Professor Gregory Monteith](https://about.uq.edu.au/experts/556)
- 2016
Doctor Philosophy
##### [A Pharmacological and Transcriptomic approach to exploring Novel Pain Targets](https://espace.library.uq.edu.au/view/UQ:411571)
Associate Advisor
Other advisors:
[Professor Irina Vetter](https://about.uq.edu.au/experts/1029)
- 2014
Doctor Philosophy
##### [Effect of perioperative medications on the interaction between breast tumour and its microenvironment](https://espace.library.uq.edu.au/view/UQ:320947)
Associate Advisor
Other advisors:
[Associate Professor Marie-Odile Parat](https://about.uq.edu.au/experts/1912)
- 2013
Doctor Philosophy
##### [A study of the activity and efficacy of beta endorphin fragments in inflamed tissue](https://espace.library.uq.edu.au/view/UQ:303942)
Associate Advisor
Other advisors:
[Dr Amitha Hewavitharana](https://about.uq.edu.au/experts/1439)
- 2012
Doctor Philosophy
##### ["Phantom Skin Pain" - Neuropathic Pain Following Burn Injury: An Examination of Incidence and Treatment](https://espace.library.uq.edu.au/view/UQ:271040)
Associate Advisor
Other advisors:
[Emeritus Professor Maree Smith](https://about.uq.edu.au/experts/32), [Professor Jeffrey Lipman](https://about.uq.edu.au/experts/5104)
- 2012
Doctor Philosophy
##### [Intracellular calcium signaling in a model of breast cancer metastasis](https://espace.library.uq.edu.au/view/UQ:272705)
Associate Advisor
Other advisors:
[Professor Gregory Monteith](https://about.uq.edu.au/experts/556), [Associate Professor Marie-Odile Parat](https://about.uq.edu.au/experts/1912)
- 2009
Doctor Philosophy
##### [Painful diabetic neuropathy: preclinical studies to improve therapeutic insight](https://espace.library.uq.edu.au/view/UQ:188298)
Associate Advisor
Other advisors:
[Emeritus Professor Maree Smith](https://about.uq.edu.au/experts/32)
- 2008
Doctor Philosophy
##### [Preclinical Studies in Painful Diabetic Neuropathy](https://espace.library.uq.edu.au/view/UQ:159450)
Associate Advisor
Other advisors:
[Professor Gregory Monteith](https://about.uq.edu.au/experts/556), [Emeritus Professor Maree Smith](https://about.uq.edu.au/experts/32)
- 2004
Doctor Philosophy
##### THE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS IN THE RAT BRAIN
Associate Advisor
Other advisors:
[Professor Gregory Monteith](https://about.uq.edu.au/experts/556)
View all 33 completed supervisions
View less
## Media
### Enquiries
Contact Professor Peter Cabot directly for media enquiries about:
- Inflammation - pharmacology
- Pain pharmacology
- Pharmacology - pain
#### Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team:
[communications@uq.edu.au](mailto:communications@uq.edu.au)
## External profiles
- [ORCID](https://orcid.org/0000-0003-1778-3753)
- [ResearcherID](https://www.webofscience.com/wos/author/record/B-2424-2013)
- [Scopus](https://www.scopus.com/authid/detail.uri?authorId=35553526700)
- [Google Scholar](https://scholar.google.com.au/citations?user= )
## Social media
- [Linkedin](https://www.linkedin.com/in/peter-cabot-93918785?trk=nav_responsive_tab_profile_pic)
- [X](https://twitter.com/peter_cabot)
Log in to Academic Portal to update your profile
[Update my profile](https://academicportal.app.uq.edu.au/profile/)